Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. [electronic resource]
Producer: 20101221Description: 1678-85 p. digitalISSN:- 1029-2403
- Acute Disease
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Antiviral Agents -- therapeutic use
- Bilirubin -- metabolism
- Cyclophosphamide -- administration & dosage
- DNA, Viral -- genetics
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Hepatitis B -- drug therapy
- Hepatitis B virus -- physiology
- Humans
- Liver Function Tests
- Lymphoma, B-Cell, Marginal Zone -- virology
- Lymphoma, Follicular -- virology
- Lymphoma, Large B-Cell, Diffuse -- virology
- Male
- Middle Aged
- Polymerase Chain Reaction
- Prednisone -- administration & dosage
- Prognosis
- Prothrombin Time
- Rituximab
- Survival Rate
- Vincristine -- administration & dosage
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.